Skip to Main Content

Paper Details

Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.
Ann Surg
7
2024
Author NameAffiliation
Kathryn L ColbornUniversity of Colorado School of Medicine
Kathryn L ColbornUniversity of Colorado School of Medicine
Kathryn L ColbornUniversity of Colorado School of Medicine
Richard D SchulickUniversity of Colorado School of Medicine
Richard D SchulickUniversity of Colorado Cancer Center, University of Colorado School of Medicine
Marco Del ChiaroUniversity of Colorado School of Medicine
Marco Del ChiaroUniversity of Colorado Cancer Center, University of Colorado School of Medicine
  • 1 - 7

Datasets

Release 1.2